(haloperidol) extended-release injectable suspension
The information contained in this learning resource contains a portion of the product information. For full details see the product information by each product owner. A full list can be found in the References tab.
No12
No12
Conversion from oral haloperidol to haloperidol decanoate can be achieved by using an initial dose of haloperidol decanoate that is 10 to 20 times the previous daily dose in oral haloperidol equivalents.
In patients who are elderly, debilitated, or stable on low doses of oral haloperidol (e.g. up to the equivalent of 10 mg/day oral haloperidol), a range of 10 to 15 times the previous daily dose in oral haloperidol equivalents is appropriate for initial conversion.
In patients previously maintained on higher doses of antipsychotics for whom a low dose approach risks recurrence of psychiatric decompensation and in patients whose long-term use of haloperidol has resulted in a tolerance to the drug, 20 times the previous daily dose in oral haloperidol equivalents should be considered for initial conversion, with downward titration on succeeding injections.12
The initial dose of haloperidol decanoate should not exceed 100 mg regardless of previous antipsychotic dose requirements. If, therefore, conversion requires more than 100 mg of haloperidol decanoate as an initial dose, that dose should be administered in two injections, ie, a maximum of 100 mg initially followed by the balance in 3 to 7 days.
No12
1-mL ampules containing a solution of haloperidol decanoate in a sesame oil vehicle.12
Medication often rests in the top part of the ampule. Before breaking the ampule, lightly tap the top of the ampule with your finger until all fluid moves to the bottom portion of the ampule. The ampule has a colored ring(s) and colored point which aids in the placement of fingers while breaking the ampule.
Hold the ampule between thumb and index finger with the colored point facing you.
Position the index finger of the other hand to support the neck of the ampule. Position the thumb so that it covers the colored point and is parallel to the colored ring(s).
Keeping the thumb on the colored point and with the index fingers close together, apply firm pressure on the colored point in the direction of the arrow to snap the ampule open.12
Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit.12
Dosing will vary depending on patient's age, clinical history, physical condition, and response to previous antipsychotic therapy
Usual maintenance range is 10-15 times the previous daily dose in oral haloperidol equivalents dependent on the clinical response of the patient.12
Q1M or Q4W12
Volume will vary depending on patient's dosage12
Not stated in the PI
A 21 gauge needle is recommended12
Deep IM12
A 21 gauge needle is recommended12
Not stated in the PI
A 21 gauge needle is recommended12
A 21 gauge needle is recommended12
n/a
1-mL ampules containing a solution of haloperidol decanoate in a sesame oil vehicle.12
No12
Store at controlled room temperature (15°-30° C, 59°-86° F).12 Do not refrigerate or freeze.
Not stated in PI
Yes12
Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit.12
Not stated in PI
Medication often rests in the top part of the ampule. Before breaking the ampule, lightly tap the top of the ampule with your finger until all fluid moves to the bottom portion of the ampule. The ampule has a colored ring(s) and colored point which aids in the placement of fingers while breaking the ampule.
Hold the ampule between thumb and index finger with the colored point facing you.
Position the index finger of the other hand to support the neck of the ampule. Position the thumb so that it covers the colored point and is parallel to the colored ring(s).
Keeping the thumb on the colored point and with the index fingers close together, apply firm pressure on the colored point in the direction of the arrow to snap the ampule open.12
Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit.12
By clicking the button below you agree to the following:
I am a US Health Care Professional.
I understand that S.C.O.P.E. is for educational purposes only and not to be used for the treatment or diagnosis of schizophrenia, nor is it a substitute for clinical judgment or guidelines.